{"id":408278,"date":"2024-10-20T05:29:53","date_gmt":"2024-10-20T05:29:53","guid":{"rendered":"https:\/\/pdfstandards.shop\/product\/uncategorized\/bsi-pd-iso-ts-22859-12022\/"},"modified":"2024-10-26T09:59:58","modified_gmt":"2024-10-26T09:59:58","slug":"bsi-pd-iso-ts-22859-12022","status":"publish","type":"product","link":"https:\/\/pdfstandards.shop\/product\/publishers\/bsi\/bsi-pd-iso-ts-22859-12022\/","title":{"rendered":"BSI PD ISO\/TS 22859-1:2022"},"content":{"rendered":"
PDF Pages<\/th>\n | PDF Title<\/th>\n<\/tr>\n | ||||||
---|---|---|---|---|---|---|---|
2<\/td>\n | National foreword <\/td>\n<\/tr>\n | ||||||
7<\/td>\n | Foreword <\/td>\n<\/tr>\n | ||||||
8<\/td>\n | Introduction <\/td>\n<\/tr>\n | ||||||
9<\/td>\n | 1 Scope 2 Normative references 3 Terms and definitions <\/td>\n<\/tr>\n | ||||||
13<\/td>\n | 4 Abbreviated terms and symbols <\/td>\n<\/tr>\n | ||||||
18<\/td>\n | 5 General requirements 5.1 General 5.2 Personnel, facilities and equipment <\/td>\n<\/tr>\n | ||||||
19<\/td>\n | 5.3 Reagents, consumables and other supplies 5.4 Management of information and data 6 Collection of umbilical cord and associated data 6.1 Information about the umbilical cord donor <\/td>\n<\/tr>\n | ||||||
20<\/td>\n | 6.2 Collection procedure <\/td>\n<\/tr>\n | ||||||
21<\/td>\n | 7 Transport of umbilical cord or hUC-MSCs and associated data to the biobank 8 Reception and traceability of umbilical cord tissue or hUC-MSCs and associated data 9 Isolation and expansion of hUC-MSCs 9.1 Processes <\/td>\n<\/tr>\n | ||||||
22<\/td>\n | 9.2 Unique identification 9.3 Testing for infectious agents 9.4 Isolation of hUC-MSCs and primary culture 9.5 Subculture and limited expansion 10 Characterization of hUC-MSCs 10.1 General <\/td>\n<\/tr>\n | ||||||
23<\/td>\n | 10.2 Viability 10.3 Morphology <\/td>\n<\/tr>\n | ||||||
24<\/td>\n | 10.4 Population doubling time and subculture\/passage 10.4.1 PDT 10.4.2 Subculture\/passage <\/td>\n<\/tr>\n | ||||||
25<\/td>\n | 10.5 Cell population purity 10.6 In vitro self-renewal assessment 10.7 Proliferation 10.8 Differentiation capability \u2014 In vitro multilineage differentiation 10.8.1 General 10.8.2 In vitro adipogenic differentiation <\/td>\n<\/tr>\n | ||||||
26<\/td>\n | 10.8.3 In vitro chondrogenic differentiation 10.8.4 In vitro osteogenic differentiation <\/td>\n<\/tr>\n | ||||||
27<\/td>\n | 10.9 Immunophenotyping by flow cytometry <\/td>\n<\/tr>\n | ||||||
28<\/td>\n | 10.10 Paracrine secretion\/expression (protein-based assay of secretome) 10.11 Immunoregulation (modulation of immune cells) <\/td>\n<\/tr>\n | ||||||
29<\/td>\n | 10.12 Microbial contamination 11 Quality control <\/td>\n<\/tr>\n | ||||||
30<\/td>\n | 12 Storage <\/td>\n<\/tr>\n | ||||||
31<\/td>\n | 13 Thawing <\/td>\n<\/tr>\n | ||||||
32<\/td>\n | 14 Disposal 15 Distribution of hUC-MSCs \u2014 Information for users <\/td>\n<\/tr>\n | ||||||
33<\/td>\n | 16 Transport of hUC-MSCs 16.1 General 16.2 hUC-MSCs frozen in ampoules or cryovials <\/td>\n<\/tr>\n | ||||||
34<\/td>\n | 16.3 Living hUC-MSC cultures <\/td>\n<\/tr>\n | ||||||
35<\/td>\n | Annex A (informative) Exemplary quality control test procedure for biobanking of hUC-MSCs <\/td>\n<\/tr>\n | ||||||
36<\/td>\n | Annex B (informative) Examples for suitable methods for the isolation and primary culture of hUC-MSCs <\/td>\n<\/tr>\n | ||||||
38<\/td>\n | Annex C (informative) Exemplary methods for characterization of hUC-MSCs <\/td>\n<\/tr>\n | ||||||
40<\/td>\n | Bibliography <\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":" Biotechnology. Biobanking. Requirements for human mesenchymal stromal cells derived from umbilical cord tissue<\/b><\/p>\n |